Loading data
REKRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 14.6 m USD | 18.77 m USD | 18.27 m USD | 18.62 m USD | 8.29 m USD |
| Operating profit | -28.89 m USD | -54.32 m USD | -42.12 m USD | -85.78 m USD | -31.83 m USD |
| Interest expense | 2.3 m USD | 2.65 m USD | 3.6 m USD | 21 k USD | 27 k USD |
| Profit before tax | -31.42 m USD | -61.37 m USD | -45.65 m USD | -84.44 m USD | — |
| Income tax expense | 42 k USD | 45 k USD | 32 k USD | -987 k USD | -3.82 m USD |
| Net income (reported basis) | -61.64 m USD | -49.46 m USD | -44.93 m USD | -83.12 m USD | -26.78 m USD |
| Net income attributable to common shareholders | — | — | — | -83.12 m USD | -26.93 m USD |
| Basic earnings per share | -0.26 USD/share | -0.71 USD/share | -0.72 USD/share | -1.67 USD/share | -0.66 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.